SBIO Holdings: ALPS Medical Breakthroughs Top Holdings
NYSEARCA: SBIOALPSHealthETFUSD
55.04+1.10 (+2.03%)
At close: Oct 9, 3:59 PM ET · Delayed 15 min
SBIO portfolio concentration
The ALPS Medical Breakthroughs ETF (SBIO) reports 10 holdings. Its biggest position is CG Oncology Inc (CGON) at 3.94% of assets. The top 10 holdings account for 30.2% of the portfolio, a moderately concentrated portfolio.
10 positions carry a weight of 1% or more. Based on the weights listed, SBIO behaves like an equal-weighted fund of about 107 stocks (the inverse Herfindahl index), a measure of how diversified it really is. Holdings and weights change over time as the fund rebalances and as share prices move.
Click any ticker to see that company's stock price, financials and news.
Summary generated from market data by MetaCap's automated system. Methodology
SBIO holdings by weight
| # | Holding | Weight |
|---|---|---|
| 1 | CGONCG Oncology Inc | 3.94% |
| 2 | TVTXTravere Therapeutics Inc Ordinary Shares | 3.48% |
| 3 | ORKAOruka Therapeutics Inc | 3.45% |
| 4 | DFTXDefinium Therapeutics Inc Ordinary Shares | 3.20% |
| 5 | MANEVeradermics Inc | 3.17% |
| 6 | DNTHDianthus Therapeutics Inc | 3.08% |
| 7 | EWTXEdgewise Therapeutics Inc | 2.76% |
| 8 | RLAYRelay Therapeutics Inc Ordinary Shares | 2.48% |
| 9 | IDYAIDEAYA Biosciences Inc | 2.32% |
| 10 | AMLXAmylyx Pharmaceuticals Inc | 2.29% |